Summary

Implantable Port Market Research Report by Type (Silicone, Polyurethane, Titanium), By Application (Chemotherapy, Antibiotic Therapy, Total Parenteral Nutrition, Blood Transfusion), By End User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics), By Insertion Method (Surgical Insertion, Percutaneous Insertion) Forecast to 2035

Market Overview
According to MRFR analysis, the Implantable Port Market Size is expected to reach USD 3,290.28 million by 2024. The implantable port market is estimated to grow at a CAGR of 6.21% between 2025 and 2035.
One of the key reasons propelling the Implantable Port Market Industry forward is the increased prevalence of chronic diseases around the world. As cancer, diabetes, and renal illnesses become increasingly common, the demand for dependable and effective long-term pharmaceutical delivery techniques, such as implantable ports, has increased. These ports offer an efficient solution for patients who require regular infusions or blood draws, allowing healthcare personnel to administer medication with minimum discomfort and consequences. With healthcare systems increasingly focused on improving patient outcomes and the necessity for long-term drug administration, implanted port technology emerges as a potential option. Furthermore, the increased demand for outpatient therapies and chronic condition care that do not require frequent hospital visits increases the attraction and requirement of these devices. Advances in technology have also enhanced the design and functionality of implantable ports, resulting in greater acceptance among healthcare professionals and patients. The increased awareness of the advantages of employing implantable ports in terms of safety, efficacy, and comfort accelerates their adoption. All of these reasons contribute to the robust growth of the Implantable Port Market Industry.
Market Segment insights
The global implantable port market is divided into three segments based on material type: silicone, polyurethane, and titanium. Titanium had the biggest market share in 2024 and is expected to grow the fastest during the forecast period (2025-2035).
The market is divided into four segments based on application: chemotherapy, antibiotic therapy, complete parenteral nutrition, and blood transfusion.
The market is divided into three segments based on the end user: hospitals, ambulatory surgery centers, and specialist clinics.
The market has been divided into two segments based on the manner of insertion: surgical and percutaneous.

Regional insights
The global implantable port market is divided into five regions: North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America held the biggest market share in 2024 and is expected to reach USD 2,416.61 million by 2035. However, Asia-Pacific is expected to develop at the fastest CAGR of 8.32% over the projection period.
The North American implantable port market was worth USD 1,382.75 million in 2024, and it is expected to increase at a CAGR of 5.20% over the forecast period. North America is further divided into the United States and Canada.
The Europe implantable port market was worth USD 972.35 million in 2024 and is expected to increase at a CAGR of 6.41% over the forecast period.
The Asia-Pacific implantable port market was worth USD 667.57 million in 2024, and it is expected to increase at a CAGR of 8.32% over the forecast period. Asia-Pacific is further divided into China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, and the Rest of Asia-Pacific.

Major Players
Easton Medical, Baxter International, Zyga Technology, Terumo, Apex Medical Technologies, Medtronic, Boston Scientific, Cook Medical, AngioDynamics, Kirwan Surgical Products, Smith's Medical, Nitinol Devices Corporation, C R Bard, Stryker, and Halyard Health are among the key players in the implantable port market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ............................................................................................................... 19
1.1 OVERVIEW .................................................................................................................................................................... 19
1.2 MARKET ATTRACTIVENESS ANALYSIS ........................................................................................................... 20
1.3 GLOBAL IMPLANTABLE PORT MARKET, BY MATERIAL TYPE ................................................................ 21
1.4 GLOBAL IMPLANTABLE PORT MARKET, BY APPLICATION ...................................................................... 22
1.5 GLOBAL IMPLANTABLE PORT MARKET, BY END USER .............................................................................. 23
1.6 GLOBAL IMPLANTABLE PORT MARKET, BY INSERTION METHOD ........................................................ 24
1.7 GLOBAL IMPLANTABLE PORT MARKET, BY REGION ................................................................................... 25
2 MARKET INTRODUCTION ............................................................................................................ 27
2.1 DEFINITION .................................................................................................................................................................. 27
2.2 SCOPE OF THE STUDY .............................................................................................................................................. 27
2.3 RESEARCH OBJECTIVE ............................................................................................................................................ 27
2.4 MARKET STRUCTURE .............................................................................................................................................. 27
3 RESEARCH METHODOLOGY ...................................................................................................... 28
3.1 OVERVIEW .................................................................................................................................................................... 28
3.2 DATA FLOW .................................................................................................................................................................. 30
3.2.1 Data Mining Process ....................................................................................................................................... 30
3.3 PURCHASED DATABASE: ......................................................................................................................................... 31
3.4 SECONDARY SOURCES: ............................................................................................................................................ 32
3.4.1 Secondary Research Data Flow: ....................................................................................................................... 33
3.5 PRIMARY RESEARCH: ............................................................................................................................................... 34
3.5.1 Primary Research Data Flow: .......................................................................................................................... 35
3.5.2 Primary Research: Number of Interviews conducted ........................................................................................ 36
3.5.3 Primary Research: Regional Coverage ............................................................................................................. 36
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ........................................................................................... 37
3.6.1 Revenue Analysis Approach ............................................................................................................................ 37
3.7 DATA FORECASTING................................................................................................................................................. 38
3.7.1 Data forecasting Type ..................................................................................................................................... 38
3.8 DATA MODELING ........................................................................................................................................................ 39
3.8.1 Microeconomic Factor Analysis: ...................................................................................................................... 39
3.8.2 Data modeling: ............................................................................................................................................... 40
3.9 TEAMS AND ANALYST CONTRIBUTION ........................................................................................................... 42
4 MARKET DYNAMICS .................................................................................................................... 44
4.1 INTRODUCTION ........................................................................................................................................................... 44
4.2 DRIVERS ......................................................................................................................................................................... 44
4.2.1 Increasing Incidences of Chronic Diseases across the globe............................................................................. 44
4.2.2 Technological Advancements .......................................................................................................................... 45
4.2.3 Better Healthcare Access ................................................................................................................................ 46
4.3 RESTRAINTS ................................................................................................................................................................ 47
4.3.1 High Cost of Implantation ............................................................................................................................... 47
4.3.2 Surgical Risks ................................................................................................................................................. 47
4.4 OPPORTUNITY ............................................................................................................................................................. 48
4.4.1 Expansion in Emerging Markets ....................................................................................................................... 48
4.4.2 Growing Aging Population ............................................................................................................................... 48
5 MARKET FACTOR ANALYSIS ...................................................................................................... 49
5.1 VALUE CHAIN ANALYSIS ....................................................................................................................................... 49
5.1.1 R&D ............................................................................................................................................................... 49
5.1.2 Manufacturing ................................................................................................................................................ 49
5.1.3 Marketing and Distribution & Channel .............................................................................................................. 49
5.1.4 Post-market Surveillance ................................................................................................................................ 50
5.2 PORTER'S FIVE FORCES MODEL ........................................................................................................................... 50
5.2.1 Threat of New Entrants ................................................................................................................................... 51
5.2.2 Bargaining Power of Suppliers ......................................................................................................................... 51
5.2.3 Threat of Substitutes ...................................................................................................................................... 52
5.2.4 Bargaining Power of Buyers ............................................................................................................................ 52
5.2.5 Intensity of Rivalry .......................................................................................................................................... 52
5.3 IMPACT OF COVID-19 ON THE GLOBAL IMPLANTABLE PORT MARKET ............................................... 53
6 GLOBAL IMPLANTABLE PORT MARKET, BY MATERIAL TYPE ................................................. 55
6.1 OVERVIEW .................................................................................................................................................................... 55
6.2 SILICONE ........................................................................................................................................................................ 57
6.3 POLYURETHANE ........................................................................................................................................................ 58
6.4 TITANIUM ..................................................................................................................................................................... 58
7 GLOBAL IMPLANTABLE PORT MARKET, BY APPLICATION ...................................................... 59
7.1 OVERVIEW .................................................................................................................................................................... 59
7.2 CHEMOTHERAPY ....................................................................................................................................................... 61
7.3 ANTIBIOTIC THERAPY ............................................................................................................................................. 62
7.4 TOTAL PARENTERAL NUTRITION ...................................................................................................................... 62
7.5 BLOOD TRANSFUSION .............................................................................................................................................. 63
8 GLOBAL IMPLANTABLE PORT MARKET, BY END USER ........................................................... 64
8.1 OVERVIEW .................................................................................................................................................................... 64
8.2 HOSPITALS ................................................................................................................................................................... 66
8.3 AMBULATORY SURGICAL CENTERS ................................................................................................................... 67
8.4 SPECIALIZED CLINICS ............................................................................................................................................... 67
9 GLOBAL IMPLANTABLE PORT MARKET, BY INSERTION METHOD ......................................... 68
9.1 OVERVIEW .................................................................................................................................................................... 68
9.2 SURGICAL INSERTION .............................................................................................................................................. 70
9.3 PERCUTANEOUS INSERTION ................................................................................................................................. 71
10 GLOBAL IMPLANTABLE PORT MARKET, BY REGION ............................................................... 72
10.1 OVERVIEW .................................................................................................................................................................... 72
10.2 NORTH AMERICA ....................................................................................................................................................... 74
10.2.1 US.................................................................................................................................................................. 77
10.2.2 CANADA ........................................................................................................................................................ 78
10.3 EUROPE .......................................................................................................................................................................... 80
10.3.1 GERMANY ...................................................................................................................................................... 83
10.3.2 FRANCE ......................................................................................................................................................... 84
10.3.3 UK ................................................................................................................................................................. 86
10.3.4 ITALY ............................................................................................................................................................. 88
10.3.5 SPAIN ............................................................................................................................................................ 90
10.3.6 RUSSIA .......................................................................................................................................................... 92
10.3.7 REST OF EUROPE ............................................................................................................................................ 94
10.4 ASIA-PACIFIC ............................................................................................................................................................... 96
10.4.1 CHINA ............................................................................................................................................................ 99
10.4.2 INDIA ............................................................................................................................................................. 100
10.4.3 JAPAN ........................................................................................................................................................... 102
10.4.4 SOUTH KOREA ................................................................................................................................................ 103
10.4.5 MALAYSIA ..................................................................................................................................................... 104
10.4.6 THAILAND ...................................................................................................................................................... 106
10.4.7 INDONESIA ..................................................................................................................................................... 107
10.4.8 REST OF ASIA-PACIFIC ................................................................................................................................... 108
10.5 SOUTH AMERICA ....................................................................................................................................................... 110
10.5.1 BRAZIL ........................................................................................................................................................... 113
10.5.2 MEXICO ......................................................................................................................................................... 114
10.5.3 ARGENTINA ................................................................................................................................................... 116
10.5.4 REST OF SOUTH AMERICA .............................................................................................................................. 117
10.6 MIDDLE EAST AND AFRICA .................................................................................................................................... 119
10.6.1 GCC COUNTRIES............................................................................................................................................. 122
10.6.2 SOUTH AFRICA ............................................................................................................................................... 123
10.6.3 REST OF MIDDLE EAST AND AFRICA ................................................................................................................ 125
11 COMPETITIVE LANDSCAPE ........................................................................................................ 128
11.1 INTRODUCTION ........................................................................................................................................................... 128
11.2 COMPANY MARKET SHARE ANALYSIS, 2024 (VALUE) ............................................................................... 128
11.3 COMPETITOR DASHBOARD..................................................................................................................................... 129
11.4 PUBLIC PLAYERS STOCK SUMMARY ................................................................................................................. 130
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL .............................................................................. 130
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ............................................................................................ 130
11.6.1 DONATION ..................................................................................................................................................... 130
11.6.2 AGREEMENT .................................................................................................................................................. 131
12 COMPANY PROFILES .................................................................................................................. 132
12.1 ANGIODYNAMICS, INC. ............................................................................................................................................. 132
12.1.1 COMPANY OVERVIEW ..................................................................................................................................... 132
12.1.2 FINANCIAL OVERVIEW .................................................................................................................................... 133
12.1.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 134
12.1.4 KEY DEVELOPMENTS ...................................................................................................................................... 135
12.1.5 SWOT ANALYSIS ............................................................................................................................................ 136
12.1.6 KEY STRATEGIES ............................................................................................................................................ 136
12.2 B. BRAUN MELSUNGEN AG .................................................................................................................................... 137
12.2.1 COMPANY OVERVIEW ..................................................................................................................................... 137
12.2.2 FINANCIAL OVERVIEW .................................................................................................................................... 138
12.2.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 138
12.2.4 KEY DEVELOPMENTS ...................................................................................................................................... 139
12.2.5 SWOT ANALYSIS ............................................................................................................................................ 139
12.2.6 KEY STRATEGIES ............................................................................................................................................ 139
12.3 BECTON, DICKINSON AND COMPANY (BD) ....................................................................................................... 140
12.3.1 COMPANY OVERVIEW ..................................................................................................................................... 140
12.3.2 FINANCIAL OVERVIEW .................................................................................................................................... 141
12.3.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 141
12.3.4 KEY DEVELOPMENTS ...................................................................................................................................... 142
12.3.5 SWOT ANALYSIS ............................................................................................................................................ 142
12.3.6 KEY STRATEGIES ............................................................................................................................................ 143
12.4 COOK MEDICAL LLC ................................................................................................................................................... 144
12.4.1 COMPANY OVERVIEW ..................................................................................................................................... 144
12.4.2 FINANCIAL OVERVIEW .................................................................................................................................... 144
12.4.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 145
12.4.4 KEY DEVELOPMENTS ...................................................................................................................................... 145
12.4.5 SWOT ANALYSIS ............................................................................................................................................ 145
12.4.6 KEY STRATEGIES ............................................................................................................................................ 146
12.5 DISTRICLASS MEDICAL SA ..................................................................................................................................... 147
12.5.1 COMPANY OVERVIEW ..................................................................................................................................... 147
12.5.2 FINANCIAL OVERVIEW .................................................................................................................................... 147
12.5.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 147
12.5.4 KEY DEVELOPMENTS ...................................................................................................................................... 147
12.5.5 SWOT ANALYSIS ............................................................................................................................................ 148
12.5.6 KEY STRATEGIES ............................................................................................................................................ 148
12.6 VYGON ............................................................................................................................................................................ 149
12.6.1 COMPANY OVERVIEW ..................................................................................................................................... 149
12.6.2 FINANCIAL OVERVIEW .................................................................................................................................... 150
12.6.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 150
12.6.4 KEY DEVELOPMENTS ...................................................................................................................................... 151
12.6.5 SWOT ANALYSIS ............................................................................................................................................ 151 12.6.6 KEY STRATEGIES ............................................................................................................................................ 152
12.7 SILMAG AG.................................................................................................................................................................... 153
12.7.1 COMPANY OVERVIEW ..................................................................................................................................... 153
12.7.2 FINANCIAL OVERVIEW .................................................................................................................................... 153
12.7.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 153
12.7.4 KEY DEVELOPMENTS ...................................................................................................................................... 153
12.7.5 SWOT ANALYSIS ............................................................................................................................................ 154
12.7.6 KEY STRATEGIES ............................................................................................................................................ 154
12.8 POLY MEDICURE LTD ................................................................................................................................................ 155
12.8.1 COMPANY OVERVIEW ..................................................................................................................................... 155
12.8.2 FINANCIAL OVERVIEW .................................................................................................................................... 156
12.8.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 156
12.8.4 KEY DEVELOPMENTS ...................................................................................................................................... 158
12.8.5 SWOT ANALYSIS ............................................................................................................................................ 158
12.8.6 KEY STRATEGIES ............................................................................................................................................ 159
12.9 PAKUMEDMEDICAL PRODUCTS GMBH ............................................................................................................. 160
12.9.1 COMPANY OVERVIEW ..................................................................................................................................... 160
12.9.2 FINANCIAL OVERVIEW .................................................................................................................................... 160
12.9.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 161
12.9.4 KEY DEVELOPMENTS ...................................................................................................................................... 161
12.9.5 SWOT ANALYSIS ............................................................................................................................................ 162
12.9.6 KEY STRATEGIES ............................................................................................................................................ 162
12.10 SOPHYSA ....................................................................................................................................................................... 163
12.10.1 COMPANY OVERVIEW ..................................................................................................................................... 163
12.10.2 FINANCIAL OVERVIEW .................................................................................................................................... 163
12.10.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 164
12.10.4 KEY DEVELOPMENTS ...................................................................................................................................... 164
12.10.5 SWOT ANALYSIS ............................................................................................................................................ 164
12.10.6 KEY STRATEGIES ............................................................................................................................................ 165
13 DATA CITATIONS ......................................................................................................................... 166